Vanderbilt Vaccine Center (VVC)
-
February 5, 2014
Discovery may pave way for RSV vaccine
Vanderbilt University scientists have contributed to a major finding, reported this week in the journal Nature, which could lead to the first effective vaccine against respiratory syncytial virus (RSV), a significant cause of infant mortality. -
January 24, 2014
Nine faculty honored with endowed chairs
Nine Vanderbilt University faculty members named to endowed chairs were honored for their academic achievements during a celebration Jan. 22 at the Student Life Center. -
December 19, 2013
Year in review 2013: A year of achievements, transition for VUMC
-
September 5, 2013
Controversial info release aids VUMC bird flu research
Vanderbilt research shows that human antibodies to the natural strain of H5N1 also protected against a dangerous lab-created airborne strain developed several years ago by scientists in the Netherlands and at the University of Wisconsin. -
August 22, 2013
Vaccine researchers ready as new flu strain evolves
A worrisome new avian influenza virus, called H7N9, emerged this spring in Eastern China. -
July 18, 2013
VU researchers ‘goldsmith’ new RSV vaccine approach
Vanderbilt vaccine researchers are using gold nanotechnology to develop a new approach to making vaccines. -
May 30, 2013
Study lays groundwork for rational T cell vaccine design
Vanderbilt University investigators have developed a new strategy for identifying the “bits” of a pathogen that spark a protective immune response.